Maritech fucoidan to undergo new clinical trial to research immuno-modulating properties
Marinova is conducting a new clinical trial, in collaboration with Nutrasource, to further explore the immunomodulatory properties of Maritech fucoidan, a marine polysaccharide found naturally in brown seaweed, in healthy adults.
Photo © iStockphoto.com/nicolas_
Marinova (Tasmania, Australia) is conducting a new clinical trial, in collaboration with Nutrasource, to further explore the immunomodulatory properties of Maritech fucoidan, a marine polysaccharide found naturally in brown seaweed, in healthy adults.
Previous research on Maritech fucoidan has shown that it may:
- Boost immune responses to vaccines
- Activate dendritic cells, natural killer cells and T cells
- Block the entry of coated viruses to cells
- Reduce lung damage commonly associated with viral infection
- Support mucosal immune health
- Dampen allergic responses
- Modulate stem cell
The new study is designed to piggyback on existing evidence that suggests Maritech fucoidan acts as an immune priming agent by increasing cytotoxic T cells and natural killer cells, reducing the levels of inflammatory cytokine interleukin-6, and modulating the key market immunoglobulin.
“High-purity, certified organic fucoidan is already included in a multitude of innovative nutritional supplements targeting immune health,” said Marinova’s CEO and managing director, Paul Garrott, in a press release. “Marinova’s investment in this new clinical trial will deepen our understanding of the unique health benefits of Maritech fucoidan.”
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
